MARC details
| 000 -LEADER |
|---|
| fixed length control field |
08926cam a2200301 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
9780323509398 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
220107t2018 xxu||||| |||| 00| 0 eng d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323509398 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9780323357623 |
| 041 ## - LANGUAGE CODE |
|---|
| Language code of text/sound track or separate title |
eng |
| 100 ## - MAIN ENTRY--PERSONAL NAME |
|---|
| Personal name |
Hoffman, Ronald |
| 245 #0 - TITLE STATEMENT |
|---|
| Title |
Hematology: basic principles and practice |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
7th ed. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) |
|---|
| Place of publication, distribution, etc. |
Philadelphia : |
| Name of publisher, distributor, etc. |
Elsevier, |
| Date of publication, distribution, etc. |
2018 |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
1 online resource (xxx, 2374 pages):illustrations (chiefly color) |
| 505 ## - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
Anatomy and physiology of the gene -- Epigenetics and epigenomics -- Genomic approaches to hematology -- Regulation of gene expression, transcription, splicing and RNA metabolism -- Protein synthesis, processing, and trafficking -- Protein architecture: relationship of form and function -- Signaling transduction and metabolomics -- Pharmacogenomics and hematologic diseases -- Hematopoietic stem cell biology -- Stem cell model of hematologic malignancies -- Hematopoietic microenvironment -- Cell adhesion -- Hematopoietic cell trafficking and chemokines -- Interactions between hematopoietic stem and progenitor cells and the bone marrow: current biology of stem cell homing and mobilization -- Vascular growth in health and disease -- Cytokine/receptor families and signal transduction -- Control of cell division -- Cell death -- Overview and compartmentalization of the immune system -- B-cell development -- T-cell immunity -- Natural killer cell immunity -- Dendritic cell biology -- Complement and immunoglobulin biology leading to clinical translation -- Tolerance and autoimmunity -- Biology of erythropoiesis, erythroid differentiation, and maturation -- Granulocytopiesis and monocytopoiesis -- Thrombocytopoiesis -- Inherited forms of bone marrow failure -- Aplastic anemia -- Paroxysmal nocturnal hemoglobinuria -- Acquired disorders of unilineage blood cell production -- Pathobiology of the human erythrocyte and its hemoglobins -- Approach to anemia in the adult and child -- Pathophysiology of iron homeostasis -- Disorders of iron metabolism: iron deficiency and overload -- Anemia of chronic diseases -- Heme biosynthesis and its disorders: porphyrias and sideroblastic anemias -- Megaloblastic anemias -- Thalassemia syndromes -- Pathobiology of sickle cell disease -- Sickle cell disease: clinical features and management -- Hemoglobin variants associated with hemolytic anemia, altered oxygen affinity, and methemoglobinemias -- Red blood cell enzymopathies -- Red blood cell membrane disorders -- Autoimmune hemolytic anemia -- Extrinsic nonimmune hemolytic anemias -- Granulocytosis, granulocytopenia, monocytosis, and monocytopenia -- Lymphocytosis, lymphocytopenia, hypergammaglobulinemia, and hypogammaglobulinemia -- Disorders of phagocyte function -- Congenital disorders of lymphocyte function -- Histiocytic disorders -- Lysosomal storage diseases: perspectives and principles -- Infectious mononucleosis and other Epstein-Barr virus-associated diseases -- Progress in the classification of hematopoietic and lymphoid neoplasms: clinical implications -- The cytogenomic basis of hematological malignancies -- Pharmacology and molecular mechanisms of antineoplastic agents for hematologic malignancies -- Pathobiology of acute myeloid leukemia -- Clinical manifestations and treatment of acute myeloid leukemia -- Myelodysplastic syndromes: biology and treatment -- Allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia and myelodysplastic syndrome in adults -- Acute myeloid leukemia in children -- Myelodysplastic syndrome and myeloproliferative syndrome in children -- Pathobiology of acute lymphoblastic leukemia -- Clinical manifestations and treatment in children of acute lymphoblastic leukemia -- Acute lymphocytic leukemia in adults -- Chronic myeloid leukemia -- The polycythemias -- Essential thrombocythemia -- Primary myelofibrosis -- Eosinophilia, eosinophil-associated diseases, chronic eosinophil leukemia, and the hypereosinophilic syndromes -- Mast cells and systemic mastocytosis -- The pathologic basis for the classification of non-Hodgkin and Hodgkin lymphomas -- Origins of Hodgkin disease -- Hodgkin lymphoma: clinical manifestations, staging, and therapy -- Origins of non-Hodgkin lymphomas -- Chronic lymphocytic leukemia -- Hairy cell leukemia -- Clinical manifestations and treatment of indolent lymphomas: marginal zone lymphomas (extranodal/malt, splenic, and nodal) -- Clinical manifestations, staging, and treatment of follicular lymphoma -- Mantle cell lymphoma -- Diagnosis and treatment of diffuse large b-cell lymphoma (DLBCL) and Burkitt lymphoma (BL) -- Viral-related lymphomas --;Malignant lymphomas in childhood -- T-cell lymphomas -- Multiple myeloma -- Waldenstrom macroglobulinemia/lymphoplasmacytic lymphoma -- Immunoglobuin light-chain amyloidosis (primary amyloidosis) -- Clinical approach to infections in the compromised host -- Psychosocial aspects of hematologic disorders -- Pain management and antiemetic therapy in hematologic disorders -- Palliative care -- Late complications of hematologic diseases and their therapies -- Overview and historical perspective of current cell-based therapies -- Practical aspects of hematologic stem cell harvesting and mobilization -- IND enabling processes for cell-based therapies -- Graft engineering and cell processing -- Principles of cell-based genetic therapies -- Mesenchymal stromal cells -- T cell therapy of hematological diseases -- NK cell-based therapies -- Immune checkpoint blockade in hematologic malignancies -- Overview and choice of donor of hematopoietic stem cell transplantation -- Indications and outcomes of allogeneic hematopoietic cell transplantation for hematologic malignancies in adults -- Unrelated donor hematopoietic cell transplantation -- Haploidentical hematopoietic cell transplantation -- Unrelated donor cord blood transplantation for hematologic malignancies -- Graft-versus-host disease and graft-versus-leukemia responses: biology and therapy -- Complications after hematopoietic cell transplantation -- Human blood group antigens and antibodies -- Principles of red blood cell transfusion -- Clinical considerations in platelet transfusion therapy -- Human leukocyte antigen and human neutrophil antigen systems -- Principles of neutrophil (granulocyte) transfusions -- Transfusion of plasma derivatives: plasma, cryoprecipitate, albumin, and immunoglobulins -- Preparation of plasma-derived and recombinant human plasma proteins -- Transfusion therapy for coagulation factor deficiencies -- Hemapheresis -- Transfusion reactions to blood and cell therapy products -- Transfusion-transmitted diseases -- Pediatric transfusion medicine -- Overview of hemostasis and thrombosis -- The blood vessel wall -- Megakaryocyte and platelet structure -- Molecular basis of platelet function -- Molecular basis of blood coagulation -- Regulatory mechanisms in hemostasis -- Clinical approach to the patient with bleeding or bruising -- Laboratory evaluation of hemostatic and thrombotic disorders -- Acquired disorders of platelet function -- Diseases of platelet number: immune thrombocytopenia, neonatal alloimmune thrombocytopenia, and posttransfusion purpura -- Thrombocytopenia caused by platelet destruction, hypersplenism, or hemodilution -- Heparin-induced thrombocytopenia -- Thrombotic thrombocytopenic purpura and the hemolytic uremic syndromes -- Hemophilia A and B -- Inhibitors in hemophilia A and B -- Rare coagulation factor deficiencies -- Structure, biology, and genetics of von Willebrand factor -- Disseminated intravascular coagulation -- Hypercoagulable states -- The antiphospholipid syndrome -- Venous thromboembolism -- Mechanical interventions in arterial and venous thrombosis -- Atherothrombosis -- Stroke -- Acute coronary syndromes -- Atrial fibrillation -- Peripheral artery disease -- Antithrombotic drugs -- Disorders of coagulation in the neonate -- Hematologic changes of pregnancy -- Hematologic manifestations of childhood illness -- Hematologic manifestations of systemic disease: liver disease -- Hematologic manifestations of systemic disease: renal disease -- Hematologic manifestations of cancer -- Integrated therapies in patients with hematologic diseases -- Hematologic manifestations of aids -- Hematologic manifestations of parasitic diseases -- Hematologic problems in the surgical patient: bleeding and thrombosis -- The spleen and its disorders -- Hematology in aging." |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Hematology. |
| 690 ## - LOCAL SUBJECT ADDED ENTRY--TOPICAL TERM (OCLC, RLIN) |
|---|
| Topical term or geographic name as entry element |
Blood |
| 9 (RLIN) |
5411 |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Benz, Edward J. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Silberstein, Leslie E. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Heslop, Helen |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Weitz, Jeffrey I. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Anastasi, John |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Salama, Mohamed E. |
| 700 ## - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Abutalib, Syed A. |
| 856 ## - ELECTRONIC LOCATION AND ACCESS |
|---|
| Uniform Resource Identifier |
<a href="https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20130233559">https://go.openathens.net/redirector/nhs?url=https://www.clinicalkey.com/dura/browse/bookChapter/3-s2.0-C20130233559</a> |